Skip to main content
Top
Published in: Journal of Community Health 2/2018

01-04-2018 | Original Paper

HIV Viral Suppression, 37 States and the District of Columbia, 2014

Authors: Kristen L. Hess, H. Irene Hall

Published in: Journal of Community Health | Issue 2/2018

Login to get access

Abstract

Achieving viral suppression among HIV-positive persons is a critical component of HIV treatment and prevention, because it leads to improved health outcomes for the individual and reduced risk of HIV transmission. There is wide variation in viral suppression across jurisdictions, races/ethnicities, age groups, and transmission risk groups. This analysis uses HIV surveillance data to examine rates of viral suppression among people living with diagnosed HIV (PLWDH) in 38 jurisdictions with complete lab reporting. Among people who received a diagnosis in 2014, the percentage with viral suppression within 12 months of diagnosis and the average time to viral suppression was assessed. Overall, among PLWDH in 2014, 57.9% were virally suppressed, and, among people with HIV diagnosed in 2014, 68.2% were suppressed within 12 months of diagnosis with an average time to suppression of 6.9 months. All outcomes varied by jurisdiction, but most had similar patterns of disparities with a few exceptions. These data highlight the need for tailored interventions at the local level. In addition, jurisdictions with relatively low viral suppression among particular groups could adapt effective interventions from jurisdictions who have higher rates of suppression.
Literature
1.
go back to reference Cohen, M. S., Chen, Y. Q., McCauley, M., et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505.CrossRefPubMedPubMedCentral Cohen, M. S., Chen, Y. Q., McCauley, M., et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505.CrossRefPubMedPubMedCentral
2.
go back to reference Lingappa, J. R., Hughes, J. P., Wang, R. S., et al. (2010). Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE, 5(9), e12598.CrossRefPubMedPubMedCentral Lingappa, J. R., Hughes, J. P., Wang, R. S., et al. (2010). Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE, 5(9), e12598.CrossRefPubMedPubMedCentral
5.
go back to reference Harrison, K. M., Kajese, T., Hall, H. I., & Song, R. (2008). Risk factor redistribution of the national HIV/AIDS surveillance data: An alternative approach. Public Health Reports (Washington, D. C.: 1974), 123(5), 618–627.CrossRef Harrison, K. M., Kajese, T., Hall, H. I., & Song, R. (2008). Risk factor redistribution of the national HIV/AIDS surveillance data: An alternative approach. Public Health Reports (Washington, D. C.: 1974), 123(5), 618–627.CrossRef
11.
go back to reference Colasanti, J., Stahl, N., Farber, E. W., Del Rio, C., & Armstrong, W. S. (2017). An exploratory study to assess individual and structural level barriers associated with poor retention and re-engagement in care among persons living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes (1999), 74(Suppl 2), S113–S120.CrossRef Colasanti, J., Stahl, N., Farber, E. W., Del Rio, C., & Armstrong, W. S. (2017). An exploratory study to assess individual and structural level barriers associated with poor retention and re-engagement in care among persons living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes (1999), 74(Suppl 2), S113–S120.CrossRef
12.
go back to reference Aberg, J. A., Gallant, J. E., Ghanem, K. G., et al. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 58(1), 1–10.CrossRef Aberg, J. A., Gallant, J. E., Ghanem, K. G., et al. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 58(1), 1–10.CrossRef
Metadata
Title
HIV Viral Suppression, 37 States and the District of Columbia, 2014
Authors
Kristen L. Hess
H. Irene Hall
Publication date
01-04-2018
Publisher
Springer US
Published in
Journal of Community Health / Issue 2/2018
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-017-0427-3

Other articles of this Issue 2/2018

Journal of Community Health 2/2018 Go to the issue